Related Experiment Video
Updated: Aug 28, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Hypericum perforatum and Its Potential Antiplatelet Effect.
Maria-do-Céu Monteiro1, Alberto C P Dias2, Daniela Costa2
1TOXRUN-CESPU Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.
This study suggests that Hypericum perforatum (HP) may inhibit platelet activation by affecting calcium mobilization and receptor expression. Further research is needed to confirm its antiplatelet properties.
Area of Science:
- Pharmacology
- Herbal Medicine
- Platelet Biology
Background:
- Hypericum perforatum (HP), known as Guan Ye Lian Qiao in traditional Chinese medicine, is widely consumed globally.
- While recognized for its antidepressant effects, HP's impact on platelet function remains largely unexplored.
- Traditional uses include treating infections and inflammation, suggesting broader biological activities.
Purpose of the Study:
- To investigate the potential effects of Hypericum perforatum (HP) on platelet activation.
- To explore the molecular mechanisms underlying HP's influence on platelet function.
Main Methods:
- Platelet activation was assessed using flow cytometry.
- Key molecular markers evaluated included intracellular calcium mobilization and the expression of activated GPIIbIIIa and P-selectin (CD62).
Main Results:
- Hypericum perforatum (HP) extracts demonstrated a potential inhibitory effect on platelet activation.
- This inhibition appears linked to reduced intracellular calcium mobilization and decreased expression of activated GPIIbIIIa receptors.
- In vitro findings suggest possible mechanisms for HP's action on platelets.
Conclusions:
- The study provides preliminary evidence for Hypericum perforatum (HP) possessing antiplatelet properties.
- Further investigation into HP's effects on hemostasis is warranted.
- HP may be recognized for its potential antiplatelet activity.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

